Abstract

Melasma is a common disorder ofhyperpigmentation of the skin, characterised by brown pigmentation primarily on the face. Given its frequent facial involvement, it has a significant impact on the quality of life of patients. Management can often be quite difficult, requiring extensive treatment periods andmultiple modalities for ongoing maintenance. The aim of this article is to provide evidence-based clinical updates to clinicians, specifically general practitioners, to assist with their everyday practice and effective assessment and treatment of melasma. Therapeutic modalities are chosen on thebasis of disease presentation, patient preference, treatment periods and side-effect profiles of treatment agents; often a combination of therapies is required.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call